Irinotecan Hydrochloride 63323-0193-55
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2009
- Listing Expires
- December 31, 2026
- Application
- ANDA077776
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 20 mg/mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Selected Package
63323-0193-55Selected1 VIAL in 1 BOX (63323-193-55) / 5 mL in 1 VIAL
Other packages for this product(1)
1 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL